位置:首页 > 蛋白库 > GIPC1_MOUSE
GIPC1_MOUSE
ID   GIPC1_MOUSE             Reviewed;         333 AA.
AC   Q9Z0G0;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   03-AUG-2022, entry version 165.
DE   RecName: Full=PDZ domain-containing protein GIPC1;
DE   AltName: Full=GAIP C-terminus-interacting protein;
DE   AltName: Full=RGS-GAIP-interacting protein;
DE   AltName: Full=RGS19-interacting protein 1;
DE   AltName: Full=SemaF cytoplasmic domain-associated protein 1;
DE            Short=SEMCAP-1;
DE   AltName: Full=Synectin;
GN   Name=Gipc1; Synonyms=Gipc, Rgs19ip1, Semcap1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH RGS19.
RX   PubMed=9770488; DOI=10.1073/pnas.95.21.12340;
RA   De Vries L., Lou X., Zhao G., Zheng B., Farquhar M.G.;
RT   "GIPC, a PDZ domain containing protein, interacts specifically with the C-
RT   terminus of RGS-GAIP.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:12340-12345(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH SEM4C.
RX   PubMed=10318831; DOI=10.1074/jbc.274.20.14137;
RA   Wang L.-H., Kalb R.G., Strittmatter S.M.;
RT   "A PDZ protein regulates the distribution of the transmembrane semaphorin,
RT   M-SemF.";
RL   J. Biol. Chem. 274:14137-14146(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH SDC4.
RX   PubMed=10911369;
RX   DOI=10.1002/1097-4652(200009)184:3<373::aid-jcp12>3.0.co;2-i;
RA   Gao Y., Li M., Chen W., Simons M.;
RT   "Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell
RT   migration.";
RL   J. Cell. Physiol. 184:373-379(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Head;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=15527962; DOI=10.1016/j.gene.2004.07.028;
RA   Zhang Y., Chittenden T., Simons M.;
RT   "Characterization of synectin expression and promoter activity.";
RL   Gene 342:29-34(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Heart, Liver, Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Inhibits endothelial cell migration (in vitro). May be
CC       involved in G protein-linked signaling (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with GLUT1 (C-terminus), ACTN1, KIF1B, MYO6 and
CC       PLEKHG5 (By similarity). Interacts with RGS19 C-terminus. Interacts
CC       with SDC4/syndecan-4 and SEMA4C/semaphorin-4C. {ECO:0000250,
CC       ECO:0000269|PubMed:10318831, ECO:0000269|PubMed:10911369,
CC       ECO:0000269|PubMed:9770488}.
CC   -!- INTERACTION:
CC       Q9Z0G0; A2ARV4: Lrp2; NbExp=2; IntAct=EBI-300855, EBI-300875;
CC       Q9Z0G0; Q64151: Sema4c; NbExp=8; IntAct=EBI-300855, EBI-987075;
CC       Q9Z0G0; Q9UM54: MYO6; Xeno; NbExp=4; IntAct=EBI-300855, EBI-350606;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O14908}.
CC       Membrane {ECO:0000250|UniProtKB:O14908}; Peripheral membrane protein
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15527962}.
CC   -!- DEVELOPMENTAL STAGE: Detected already at 4.5 dpc, expression peaks at
CC       11.5-12.5 dpc and gradually declines to its adult levels by 18.5 dpc.
CC       {ECO:0000269|PubMed:15527962}.
CC   -!- SIMILARITY: Belongs to the GIPC family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF089818; AAC67550.1; -; mRNA.
DR   EMBL; AF104358; AAD12262.1; -; mRNA.
DR   EMBL; AF061263; AAC72311.1; -; mRNA.
DR   EMBL; AK086506; BAC39680.1; -; mRNA.
DR   EMBL; BC003490; AAH03490.1; -; mRNA.
DR   CCDS; CCDS22457.1; -.
DR   RefSeq; NP_061241.1; NM_018771.3.
DR   PDB; 5V6B; X-ray; 1.90 A; A/B=52-327.
DR   PDB; 5V6E; X-ray; 3.51 A; A/C/E/G/I=258-333.
DR   PDB; 5V6T; X-ray; 3.19 A; B=52-333.
DR   PDB; 7NRN; NMR; -; A=255-333.
DR   PDBsum; 5V6B; -.
DR   PDBsum; 5V6E; -.
DR   PDBsum; 5V6T; -.
DR   PDBsum; 7NRN; -.
DR   AlphaFoldDB; Q9Z0G0; -.
DR   SMR; Q9Z0G0; -.
DR   BioGRID; 212526; 9.
DR   CORUM; Q9Z0G0; -.
DR   DIP; DIP-33281N; -.
DR   ELM; Q9Z0G0; -.
DR   IntAct; Q9Z0G0; 6.
DR   MINT; Q9Z0G0; -.
DR   STRING; 10090.ENSMUSP00000019577; -.
DR   iPTMnet; Q9Z0G0; -.
DR   PhosphoSitePlus; Q9Z0G0; -.
DR   EPD; Q9Z0G0; -.
DR   jPOST; Q9Z0G0; -.
DR   MaxQB; Q9Z0G0; -.
DR   PaxDb; Q9Z0G0; -.
DR   PeptideAtlas; Q9Z0G0; -.
DR   PRIDE; Q9Z0G0; -.
DR   ProteomicsDB; 268880; -.
DR   Antibodypedia; 13703; 297 antibodies from 34 providers.
DR   DNASU; 67903; -.
DR   Ensembl; ENSMUST00000019577; ENSMUSP00000019577; ENSMUSG00000019433.
DR   GeneID; 67903; -.
DR   KEGG; mmu:67903; -.
DR   UCSC; uc009mkr.1; mouse.
DR   CTD; 10755; -.
DR   MGI; MGI:1926252; Gipc1.
DR   VEuPathDB; HostDB:ENSMUSG00000019433; -.
DR   eggNOG; KOG3938; Eukaryota.
DR   GeneTree; ENSGT00390000003420; -.
DR   HOGENOM; CLU_044527_1_0_1; -.
DR   InParanoid; Q9Z0G0; -.
DR   OMA; QIEPQFD; -.
DR   OrthoDB; 1442796at2759; -.
DR   PhylomeDB; Q9Z0G0; -.
DR   TreeFam; TF313878; -.
DR   BioGRID-ORCS; 67903; 6 hits in 74 CRISPR screens.
DR   ChiTaRS; Gipc1; mouse.
DR   PRO; PR:Q9Z0G0; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; Q9Z0G0; protein.
DR   Bgee; ENSMUSG00000019433; Expressed in lip and 252 other tissues.
DR   ExpressionAtlas; Q9Z0G0; baseline and differential.
DR   Genevisible; Q9Z0G0; MM.
DR   GO; GO:0005903; C:brush border; ISO:MGI.
DR   GO; GO:0005938; C:cell cortex; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0043198; C:dendritic shaft; IDA:MGI.
DR   GO; GO:0043197; C:dendritic spine; IDA:MGI.
DR   GO; GO:0030139; C:endocytic vesicle; ISO:MGI.
DR   GO; GO:0098978; C:glutamatergic synapse; IMP:SynGO.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:MGI.
DR   GO; GO:0012506; C:vesicle membrane; IDA:MGI.
DR   GO; GO:0003779; F:actin binding; IPI:MGI.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:MGI.
DR   GO; GO:0017022; F:myosin binding; IPI:MGI.
DR   GO; GO:0030165; F:PDZ domain binding; ISO:MGI.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:MGI.
DR   GO; GO:0098761; P:cellular response to interleukin-7; IDA:MGI.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:MGI.
DR   GO; GO:0043542; P:endothelial cell migration; IMP:MGI.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:MGI.
DR   GO; GO:0014047; P:glutamate secretion; IMP:MGI.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; ISO:MGI.
DR   GO; GO:0048023; P:positive regulation of melanin biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0006605; P:protein targeting; IMP:MGI.
DR   GO; GO:0031647; P:regulation of protein stability; IDA:BHF-UCL.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IMP:MGI.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IMP:SynGO.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR017379; GIPC1/2/3.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   PANTHER; PTHR12259; PTHR12259; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   PIRSF; PIRSF038083; UCP038083_GIPC; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Membrane; Phosphoprotein; Reference proteome.
FT   CHAIN           1..333
FT                   /note="PDZ domain-containing protein GIPC1"
FT                   /id="PRO_0000087493"
FT   DOMAIN          133..213
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          1..53
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          223..244
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         68
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14908"
FT   MOD_RES         222
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14908"
FT   MOD_RES         225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14908"
FT   MOD_RES         232
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14908"
FT   MOD_RES         242
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O14908"
FT   MOD_RES         247
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14908"
FT   CONFLICT        39
FT                   /note="A -> G (in Ref. 1; AAC67550)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        53
FT                   /note="A -> S (in Ref. 1; AAC67550)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        141
FT                   /note="E -> D (in Ref. 1; AAC67550)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        226
FT                   /note="A -> S (in Ref. 1; AAC67550)"
FT                   /evidence="ECO:0000305"
FT   STRAND          60..64
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          71..73
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   HELIX           79..89
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   HELIX           94..96
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          97..103
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   HELIX           109..111
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          115..118
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          123..137
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          145..149
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          151..153
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          155..160
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   TURN            165..168
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          177..181
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   HELIX           191..199
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          206..214
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          241..245
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          247..249
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   STRAND          251..255
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   HELIX           259..276
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   HELIX           281..291
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   HELIX           297..308
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   TURN            309..311
FT                   /evidence="ECO:0007829|PDB:5V6B"
FT   HELIX           315..324
FT                   /evidence="ECO:0007829|PDB:5V6B"
SQ   SEQUENCE   333 AA;  36129 MW;  52E5ED6092EA9300 CRC64;
     MPLGLGRRKK APPLVENEEA EPSRSGLGVG EPGPLGGSAA GESQMGLPPP PAALRPRLVF
     HTQLAHGSPT GRIEGFTNVK ELYGKIAEAF RLPAAEVMFC TLNTHKVDMD KLLGGQIGLE
     DFIFAHVKGQ RKEVEVFKSE EALGLTITDN GAGYAFIKRI KEGSVIDHIQ LISVGDMIEA
     INGQSLLGCR HYEVARLLKE LPRGRTFTLK LTEPRKAFDM ISQRSAGGHP GSGPQLGTGR
     GTLRLRSRGP ATVEDLPSAF EEKAIEKVDD LLESYMGIRD TELAATMVEL GKDKRNPDEL
     AEALDERLGD FAFPDEFVFD VWGAIGDAKV GRY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025